معرفی
Ali Tavallaei serves as an Assistant Professor at Toronto Metropolitan University since 2019 and concurrently holds a Visiting Scientist position at Sunnybrook Research Institute. He is also the President and Co-founder of Magellan Biomedical Inc. (2018-present) and Vital Biomedical Technologies Inc. (2012-present), demonstrating strong industry engagement in medical device commercialization.
His academic foundation includes:
- Ph.D. in Biomedical Engineering from Western University (2010-2015)
- Medical Innovation Fellowship at University of Minnesota/Western University (2015-2016)
- Postdoctoral Fellowship at Sunnybrook Research Institute, University of Toronto (2016-2019)
Dr. Tavallaei's research centers on image guided therapy with emphasis on solving unmet clinical needs in minimally invasive interventions. His core focus areas include:
- Cardiovascular device innovation and evaluation
- Medical imaging instrumentation for real-time guidance
- Robotic systems for catheter navigation
- Mechatronic solutions for therapeutic delivery
Recent publications (2023-2026) reveal a concentrated effort in developing next-generation catheter technologies, including steering mechanisms (CathPilot), imaging tools (CathEye, CathCam), and specialized devices for vascular interventions. The research consistently emphasizes performance validation, mechanical characterization, and clinical feasibility across peripheral artery disease, aneurysm repair, and cardiac ablation applications.
As director of the Medical Devices and Systems Lab, Dr. Tavallaei leads a translational research program focused on fundamental advances in cardiovascular disease management. The lab's workflow integrates solution design, system verification, preclinical testing, and technology transfer to address global healthcare challenges posed by cardiovascular diseases—the leading cause of death worldwide.
